PR Newswire
15 Nov 2022, 23 GMT+10
MELBOURNE, Australia, Nov. 15, 2022 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to advise that CEO and Managing Director, Dr David Foster will present at the World Antiviral Congress 2022 in San Diego, USA which runs from 28 November - 1 December 2022.
The World Antiviral Congress is an invitation only event, focused on helping companies to accelerate their antiviral research. This year's theme is "Bringing translational antiviral drug discovery and development to the market".
"The Congress presents a valuable platform for Island to present to the world's leading experts in the field of infectious disease about the vast potential around our investigational dengue fever drug, ISLA-101" said Dr David Foster.
"We will also discuss opportunities we have to rapidly progress new treatments for emerging viral threats, and we welcome discussions with prospective commercial partners and collaborators," said Dr David Foster.
Island presentation details
Date & time: Tuesday 29 November at 4.50pm PDT
Presenter: Dr David Foster, CEO, Island Pharmaceuticals
Presentation title: A repurposing antiviral solution for the prevention and treatment of Dengue
One-on-one meetings can be scheduled by contacting Island directly via info@islandpharmaceuticals.com.
Island (ASX: ILA) is a mid-clinical-stage drug repurposing company, focused on the topical area of antiviral therapeutics for infectious diseases. Our lead asset is ISLA-101, a drug with a well- established safety profile, being repurposed for the prevention and treatment of dengue[2] fever and other mosquito (or vector) borne diseases. The Company is close to commencing a Phase 2a clinical trial in dengue-infected subjects.
If ISLA-101 achieves FDA approval, and certain other criteria are met, Island may be eligible to obtain a "Priority Review Voucher" at the time of FDA approval. This means that as well as getting approval to manufacture and sell ISLA-101, the Priority Review Voucher (PRV) could permit Island to expedite the FDA approval process for a new drug or sell the PRV in a secondary market.
Island encourages all current investors to go paperless by registering their details with the Company's share registry, Automic Registry Services, whose contact info is housed on the Shareholder Services page of the Company's website.
Visit www.islandpharmaceuticals.com for more on Island.
Get a daily dose of Malaysia Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.
More InformationKATHMANDU, Nepal - On Saturday, as many as 465 vultures, including some critically endangered species, were spotted in a single ...
ISLAMABAD, Pakistan - Former President General (retd) Pervez Musharraf died in a Dubai hospital on Sunday at the age of ...
NAYPYITAW, Myanmar - According to an announcement broadcast by state-run media on Wednesday evening, members of Myanmar's National Defence and ...
LAHORE, Pakistan - Former Prime Minister Imran Khan questioned Prime Minister Shehbaz Sharif's "shamelessness" in a social media post criticizing ...
Future energy cooperation will be based on market prices, according to CEO Igor SechinRussia is willing to meet India's oil ...
Manama [Bahrain], February 6 (ANI): The Asian Cricket Council (ACC) has increased Afghanistan's share from Asia Cup earnings as a ...
WASHINGTON D.C.: A report released this week detailed how, in January, layoffs in the US reached a more than two-year ...
PARIS, France: Following an 18 month controversy that exposed the workings of the global jet market, Airbus and Qatar Airways ...
TOKYO, Japan: Japan is preparing to revise legislation to allow it to restrict the export of advanced semiconductor manufacturing equipment ...
LONDON, England: Energy giant Shell Oil has announced a record profit of nearly $40 billion in 2022, capping an eventful ...
TOKYO, Japan: Honda has announced that it will manufacture a new hydrogen fuel cell system, which was jointly developed with ...
IRVINE, California: In an effort to cut costs in preparation for an industry-wide price war, electric vehicle manufacturer Rivian Automotive, ...